Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Clinical Research

Obesity paradox and stroke outcomes according to stroke subtype: a propensity score-matched analysis

International Journal of Obesity volume 47, pages 669–676 (2023)Cite this article

Subjects

Abstract

Objective

Obesity has traditionally been considered a risk factor for ischemic stroke. However, some clinical observations have reported a complex relationship between patients who are overweight or obese with paradoxically better stroke outcomes. Stroke subtypes have differing distributions of risk factors, so this study aimed to explain the relationship between body mass index (BMI) and functional prognosis according to stroke subtype.

Methods

A prospective institutional database on stroke was accessed between March 2014 and December 2021, and consecutive patients with ischemic stroke were retrospectively selected. BMI was categorized into five groups (underweight, normal weight, overweight, obese, and morbid obesity). The outcome of interest in this study was the modified Rankin Scale (mRS) at 90 d, which was divided into favorable (mRS = 0–2) and unfavorable (mRS ≥ 3) groups. The relationship between functional outcome and BMI was analyzed according to stroke subtype.

Results

Among 2779 patients with stroke, 913 (32.9%) had unfavorable outcomes. After a propensity score-matched analysis, obesity was inversely associated with unfavorable outcomes (adjusted odds ratio [aOR] = 0.61, 95% confidence interval [95% CI]: 0.46–0.80) in all patients with stroke. Among the stroke subtypes, overweight (aOR = 0.38, 95% CI: 0.20–0.74) and obese (aOR = 0.40, 95% CI: 0.21–0.76) groups were inversely associated with unfavorable outcomes in the cardioembolism subtype. Obesity (aOR = 0.55, 95% CI: 0.32–0.95) was inversely associated with unfavorable outcomes in the small vessel disease subtype. There was no significant relationship between stroke outcome and BMI classification in the large artery disease subtype.

Conclusions

These findings suggest that the obesity paradox in ischemic stroke outcomes might differ according to the stroke subtype.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Flowchart of patient inclusion and exclusion criteria.
Fig. 2: The association of BMI with unfavorable outcomes (3-month mRS) for all stroke subtypes.
Fig. 3: Logistic regression models for odds of unfavorable outcomes (3-month mRS) in patients with various stroke subtypes according to BMI.

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this article and its supplementary material files. Further inquiries can be directed to the corresponding author.

References

  1. Chandramouli C, Tay WT, Bamadhaj NS, Tromp J, Teng TK, Yap JJL, et al. Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study. PLOS Med. 2019;16:e1002916.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861–7.

    CAS  PubMed  Google Scholar 

  3. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, Flegal KM, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults (vol 293, pg 1868, 2005). JAMA. 2005;294:182–182.

    Google Scholar 

  4. Bazzano LA, Gu DF, Whelton MR, Wu XQ, Chen CS, Duan XF, et al. Body mass index and risk of stroke among Chinese men and women. Ann Neurol. 2010;67:11–20.

    PubMed  PubMed Central  Google Scholar 

  5. Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121:230–6.

    PubMed  Google Scholar 

  6. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Männistö S, Jousilahti P. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med. 2007;167:1420–7.

    PubMed  Google Scholar 

  7. Towfighi A, Ovbiagele B. The impact of body mass index on mortality after stroke. Stroke. 2009;40:2704–8.

    PubMed  Google Scholar 

  8. Funada S, Shimazu T, Kakizaki M, Kuriyama S, Sato Y, Matsuda-Ohmori K, et al. Body mass index and cardiovascular disease mortality in Japan: the Ohsaki Study. Prev Med. 2008;47:66–70.

    PubMed  Google Scholar 

  9. Crisp AH, Mcguiness B. Jolly fat – Relation between obesity and psychoneurosis in general population. Br Med J. 1976;1:7–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61.

    PubMed  Google Scholar 

  11. Lee EY, Lee YH, Yi SW, Shin SA, Yi JJ. BMI and all-cause mortality in normoglycemia, impaired fasting glucose, newly diagnosed diabetes, and prevalent diabetes: a cohort study. Diabetes Care. 2017;40:1026–33.

    PubMed  Google Scholar 

  12. Doehner W, Schenkel J, Anker SD, Springer J, Audebert HJ. Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial. Eur Heart J. 2013;34:268–77.

    PubMed  Google Scholar 

  13. Andersen KK, Olsen TS. The obesity paradox in stroke: Lower mortality and lower risk of readmission for recurrent stroke in obese stroke patients. Int J Stroke. 2015;10:99–104.

    PubMed  Google Scholar 

  14. Kim BJ, Lee SH, Ryu WS, Kim CK, Lee J, Yoon BW. Paradoxical longevity in obese patients with intracerebral hemorrhage. Neurology. 2011;76:567–73.

    CAS  PubMed  Google Scholar 

  15. World Health Organization. Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications, Sydney Australia, 2000.

  16. Adams HP Jr, Biller J. Classification of subtypes of ischemic stroke: History of the trial of org 10172 in acute stroke treatment classification. Stroke. 2015;46:e114–e117.

    PubMed  Google Scholar 

  17. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994;25:2220–6.

    CAS  PubMed  Google Scholar 

  18. Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:3020–35.

    CAS  PubMed  Google Scholar 

  19. Li Z, Zhou T, Li Y, Chen P, Chen L. Anemia increases the mortality risk in patients with stroke: a meta-analysis of cohort studies. Sci Rep. 2016;6:26636.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499–511.

    PubMed  Google Scholar 

  21. Jung JM, Kwon DY, Han C, Jo I, Jo SA, Park MH. Increased carotid intima-media thickness and plasma homocysteine levels predict cardiovascular and all-cause death: a population-based cohort study. Eur Neurol. 2013;70:1–5.

    CAS  PubMed  Google Scholar 

  22. Kelly DM, Ademi Z, Doehner W, Lip GYH, Mark P, Toyoda K. Chronic kidney disease and cerebrovascular disease: consensus and guidance From a KDIGO controversies conference. Stroke. 2021;52:e328–e346.

    CAS  PubMed  Google Scholar 

  23. Blanc B: nutritional anemias. Report of a WHO Scientific Group [WHO Tech Rep. Ser.]. 405. 1968. pp 1–40.

  24. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. The ACCP/SCCM Consensus Conference Committee. 1992;101:1644–55.

    CAS  Google Scholar 

  25. Kim J, Park MH, Kim E, Han C, Jo SA, Jo I. Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population. J Nutr. 2007;137:2093–7.

    CAS  PubMed  Google Scholar 

  26. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res. 2007;16:219–42.

    PubMed  Google Scholar 

  27. Rosenbaum PR, Rubin DB. Constructing a control-group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33–38.

    Google Scholar 

  28. Pirson FAV, Hinsenveld WH, Staals J, de Greef BTA, van Zwam WH, Dippel DWJ, et al. The effect of body mass index on outcome after endovascular treatment in acute ischemic stroke patients: a post hoc analysis of the mr clean trial. Cerebrovasc Dis. 2019;48:200–6.

    PubMed  Google Scholar 

  29. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.

    PubMed  Google Scholar 

  30. Burke DT, Al-Adawi S, Bell RB, Easley K, Chen S, Burke DP. Effect of body mass index on stroke rehabilitation. Arch Phys Med Rehabil. 2014;95:1055–9.

    PubMed  Google Scholar 

  31. Zhao L, Du W, Zhao X, Liu L, Wang C, Wang Y, et al. Favorable functional recovery in overweight ischemic stroke survivors: Findings from the China National Stroke Registry. J Stroke Cerebrovasc Dis. 2014;23:e201–206.

    PubMed  Google Scholar 

  32. Kim Y, Kim CK, Jung S, Yoon BW, Lee SH. Obesity-stroke paradox and initial neurological severity. J Neurol Neurosurg Psychiatry. 2015;86:743–7.

    PubMed  Google Scholar 

  33. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.

    PubMed  Google Scholar 

  34. Twig G, Yaniv G, Levine H, Leiba A, Goldberger N, Derazne E, et al. Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood. N Engl J Med. 2016;374:2430–40.

    PubMed  Google Scholar 

  35. Kang SH, Choi EK, Han KD, Lee SR, Lim WH, Cha MJ, et al. Underweight is a risk factor for atrial fibrillation: A nationwide population-based study. Int J Cardiol. 2016;215:449–56.

    PubMed  Google Scholar 

  36. Boriani G, Ruff CT, Kuder JF, Shi MG, Lanz HJ, Rutman H, et al. Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2019;40:1541–50. +

    CAS  PubMed  Google Scholar 

  37. Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, et al. The ‘obesity paradox’ in atrial fibrillation: observations from the Aristotle (apixaban for Reduction in Stroke and Other thromboembolic Events in atrial fibrillation) trial. Eur Heart J. 2016;37:2869–78.

    PubMed  Google Scholar 

  38. Scherbakov N, von Haehling S, Anker SD, Dirnagl U, Doehner W. Stroke induced sarcopenia: muscle wasting and disability after stroke. Int J Cardiol. 2013;170:89–94.

    PubMed  Google Scholar 

  39. Ohyama K, Watanabe M, Nosaki Y, Hara T, Iwai K, Mokuno K, et al. Correlation between skeletal muscle mass deficit and poor functional outcome in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29:104623.

    PubMed  Google Scholar 

  40. DeLany J. Leptin hormone and other biochemical influences on systemic inflammation. J Bodyw Mov Ther. 2008;12:121–32.

    PubMed  Google Scholar 

  41. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32.

    PubMed  Google Scholar 

  42. Kalantar-Zadeh K, Horwich TB, Oreopoulos A, Kovesdy CP, Younessi H, Anker SD, et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care. 2007;10:433–42.

    PubMed  Google Scholar 

  43. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrão AB, Gold P, et al. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm in cortisol and leptin secretion. J Clin Endocrinol Metab. 1998;83:280–3.

    CAS  PubMed  Google Scholar 

  44. Rozen G, Elbaz-Greener G, Margolis G, Marai I, Heist EK, Ruskin JN, et al. The obesity paradox in real-world nation-wide cohort of patients admitted for a stroke in the U.S. J Clin Med. 2022;11:1678.

    PubMed  PubMed Central  Google Scholar 

  45. Hong S, Park JH, Han K, Lee CB, Kim DS, Yu SH. Association between obesity and cardiovascular disease in elderly patients with diabetes: a retrospective cohort study. J Clin Endocrinol Metab. 2022;107:e515–e527.

    PubMed  Google Scholar 

  46. Rhéaume C, Leblanc MÈ, Poirier P. Adiposity assessment: explaining the association between obesity, hypertension and stroke. Expert Rev Cardiovasc Ther. 2011;12:1557–64.

    Google Scholar 

  47. Neeland IJ, Poirier P, Després JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137:1391–406.

    PubMed  PubMed Central  Google Scholar 

  48. Nazare JA, Smith JD, Borel AL, Haffner SM, Balkau B, Ross R, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: The international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am J Clin Nutr. 2012;96:714–26.

    CAS  PubMed  Google Scholar 

  49. Lam CSP, Teng TK, Tay WT, Anand I, Zhang S, Shimizu W, et al. Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. Eur Heart J. 2016;37:3141–53.

    PubMed  Google Scholar 

  50. Hori M, Connolly SJ, Zhu J, Liu LS, Lau CP, Pais P, et al. Dabigatran Versus warfarin effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke. 2013;44:1891–6.

    CAS  PubMed  Google Scholar 

  51. Wong KSL, Hu DY, Oomman A, Tan RS, Patel MR, Singer DE, et al. Rivaroxaban for stroke prevention in East Asian patients From the ROCKET AF trial. Stroke. 2014;45:1739–47.

    CAS  PubMed  Google Scholar 

  52. Goto S, Zhu J, Liu LS, Oh BH, Wojdyla DM, Aylward P, et al. Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (Aristotle) trial. Am Heart J. 2014;168:303–9.

    CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (R2015433).

Author information

Authors and Affiliations

  1. Department of Neurology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea

    Sang-Hun Lee, Jin-Man Jung & Moon-Ho Park

Authors
  1. Sang-Hun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin-Man Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Moon-Ho Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S-HL designed the study, collected the data, and wrote the manuscript. J-MJ revised the manuscript. M-HP designed the study, collected the data, and revised the manuscript.

Corresponding author

Correspondence to Moon-Ho Park.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, SH., Jung, JM. & Park, MH. Obesity paradox and stroke outcomes according to stroke subtype: a propensity score-matched analysis. Int J Obes 47, 669–676 (2023). https://doi.org/10.1038/s41366-023-01318-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-023-01318-0

This article is cited by

Search

Advanced search

Quick links